Association between fibroblast growth factor receptor 4 Gly388Arg polymorphism and ischaemic stroke

Journal of International Medical Research

Volumn 40, Issue 5, 2012, Pages 1708-1714

  Zhang, H F ^a,b   Zhao, K J ^a   Yang, P F ^a   Fang, Y B ^a   Zhang, Y H ^a   Liu, J M ^a   Huang, Q H ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Chinese population; FGFR4 Gly388Arg polymorphism; Fibroblast growth factor receptor; Genetic polymorphism; Ischaemic stroke

Indexed keywords

ARGININE; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GLYCINE; FGFR4 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE PATIENT; AGED; AMINO ACID SUBSTITUTION; BRAIN INFARCTION; GENETIC PREDISPOSITION; GENETICS;

AGED; AMINO ACID SUBSTITUTION; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4;

EID: 84877249781     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/030006051204000509     Document Type: Article

References (35)

1. Hassan A, Markus HS: Genetics and ischaemic stroke. Brain 2000; 123: 1784-1812.
2. Jackson CL, Reidy MA: Basic fibroblast growth factor: its role in the control of smooth muscle cell migration. Am J Pathol 1993; 143: 1024-1031.
3. Winkles JA, Friesel R, Burgess WH, et al: Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Proc Natl Acad Sci U S A 1987; 84: 7124-7128.
4. Tan EM, Levine E, Sorger T, et al: Heparin and endothelial cell growth factor modulate collagen and proteoglycan production in human smooth muscle cells. Biochem Biophys Res Commun 1989; 163: 84-92.
5. Folkman J, Klagsbrun M: Angiogenic factors. Science 1987; 235: 442-447.
6. Baird A, Mormède P, Böhlen P: Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophagederived growth factor. Biochem Biophys Res Commun 1985; 126: 358-364.
7. Schweigerer L, Neufeld G, Friedman J, et al: Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 1987; 325: 257-259.
8. Hughes SE, Crossman D, Hall PA: Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc Res 1993; 27: 1214-1219.
9. Lindner V, Lappi DA, Baird A, et al: Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991; 68: 106-113.
10. Bjornsson TD, Dryjski M, Tluczek J, et al: Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci U S A 1991; 88: 8651-8655.
11. Reidy MA, Lindner V: Basic FGF and growth of arterial cells. Ann NY Acad Sci 1991; 638: 290-299.
12. Wu MT, Hwang ST: CXCR5-transduced bone marrow-derived dendritic cells traffic to B cell zones of lymph nodes and modify antigenspecific immune responses. J Immunol 2002; 168: 5096-5102.
13. Casscells W, Lappi DA, Olwin BB, et al: Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors. Proc Natl Acad Sci U S A 1992; 89: 7159-7163.
14. Cuevas P, Gonzalez AM, Carceller F, et al: Vascular response to basic fibroblast growth factor when infused onto the normal adventitia or into the injured media of the rat carotid artery. Circ Res 1991; 69: 360-369.
15. Nabel EG, Yang ZY, Plautz G, et al: Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 1993; 362: 844-846.
16. Eisemann A, Ahn JA, Graziani G, et al: Alternative splicing generates at least five different isoforms of the human basic-FGF receptor. Oncogene 1991; 6: 1195-1202.
17. Champion-Arnaud P, Ronsin C, Gilbert E, et al: Multiple mRNAs code for proteins related to the BEK fibroblast growth factor receptor. Oncogene 1991; 6: 979-987.
18. Werner S, Duan DS, De Vries C, et al: Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol 1992; 12: 82-88.
19. Templeton TJ, Hauschka SD: FGF-mediated aspects of skeletal muscle growth and differentiation are controlled by a high affinity receptor, FGFRI. Dev Biol 1992; 154: 169-181.
20. Bange J, Prechtl D, Cheburkin Y, et al: Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer Res 2002; 62: 840-847.
21. Wang J, Yu W, Cai Y, et al: Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression. Neoplasia 2008; 10: 847-856.
22. Frullanti E, Berking C, Harbeck N, et al: Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor. Eur J Cancer Prev 2011; 20: 340-347.
23. Ma L, Zhang H, Han C, et al: Fibroblast growth factor receptor 4 polymorphisms and susceptibility to coronary artery disease. DNA Cell Biol 2012; 31: 1064-1069.
24. Wang W, Song H, Liu J, et al: CD86+ 1057G/A polymorphism and susceptibility to osteosarcoma. DNA Cell Biol 2011; 30: 925-929.
25. Liu Y, He Z, Feng D, et al: Cytotoxic Tlymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma. DNA Cell Biol 2011; 30: 1051-1055.
26. Ma L, Song H, Zhang M, et al: Lysyl oxidase G473A polymorphism is associated with increased risk of coronary artery diseases. DNA Cell Biol 2011; 30: 1033-1037.
27. Yang Y, Zhou Y, Lu M, et al: Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma. Mol Carcinog 2012; 51: 515-521.
28. Xu W, Li Y, Wang X, et al: FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects. Eur J Cancer 2010; 46: 3332-3338.
29. Eswarakumar VP, Lax I, Schlessinger J: Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005; 16: 139-149.
30. Matsumoto-Yoshitomi S, Habashita J, Nomura C, et al: Autocrine transformation by fibroblast growth factor 9 (FGF-9) and its possible participation in human oncogenesis. Int J Cancer 1997; 71: 442-450.
31. Leung HY, Gullick WJ, Lemoine NR: Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer. Int J Cancer 1994; 59: 667-675.
32. Jaakkola S, Salmikangas P, Nylund S, et al: Amplification of fgfr4 gene in human breast and gynecological cancers. Int J Cancer 1993; 54: 378-382.
33. Lehtola L, Partanen J, Sistonen L, et al: Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breastcancer cells. Int J Cancer 1992; 50: 598-603.
34. Takahashi A, Sasaki H, Kim SJ, et al: Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique. Biochem Biophys Res Commun 1999; 257: 855-859.
35. Mikawa T: Retroviral targeting of FGF and FGFR in cardiomyocytes and coronary vascular cells during heart development. Ann NY Acad Sci 1995; 752: 506-516.